PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

3009, 2022

Mariam M Al-Omari et al., Review of current in vitro COVID-19 diagnostics methods

2809, 2022

Silvia Chiesa et al., Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma

1509, 2022

Eleonora Nardi et al., A study on the placenta in stillbirth: an evaluation of molecular alterations through next generation sequencing

109, 2022

Alessandro Dal Maso et al., EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience

3008, 2022

Valentina Grespi et al., Human neural stem cells drug product: Microsatellite instability analysis

108, 2022

Pina Ziranu et al., CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors

2307, 2022

Chiara Nicolazzo et al., A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance

507, 2022

Liborio Torregrossa et al., The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution

2506, 2022

Thais Maloberti et al., BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases

1406, 2022

Silvia Bessi et al., Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study

1306, 2022

Monica Niger et al., MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.

906, 2022

Jana Fassunke et al., Biomarker testing in lung cancer patients- upscaling the fast track analysis

Previous 567 Next